Jilin Aodong Pharmaceutical Group: Voluntary Information Disclosure Notice Concerning the Holding Subsidiary Obtaining a Notice of Approval for Drug Supplementation Applications

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.